These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 28510704)

  • 1. Skin Disorders in Egyptian Children with β-Thalassemia Major.
    Fahmey SS; Taha G; El-Refaey A; Adly S
    J Trop Pediatr; 2018 Apr; 64(2):104-109. PubMed ID: 28510704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous manifestations in Egyptian children with beta-thalassemia major: Relationship with serum ferritin, thyroid profile, and treatment modalities.
    El-Dash H; Adel S
    Pediatr Dermatol; 2018 Sep; 35(5):639-643. PubMed ID: 29943859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin diseases in patients with beta-thalassemia major.
    Dogramaci AC; Savas N; Ozer B; Duran N
    Int J Dermatol; 2009 Oct; 48(10):1057-61. PubMed ID: 19785086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous Manifestations in Patients with Beta-Thalassemia Major.
    Zulfiqar Z; Kanwal A; Chaudhry M; Aadil M; Qaiser S; Malik A; Abdullah M
    J Mother Child; 2023 Jun; 27(1):142-146. PubMed ID: 37804540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Premature atherosclerosis in children with beta-thalassemia major: New diagnostic marker.
    Sherief LM; Dawood O; Ali A; Sherbiny HS; Kamal NM; Elshanshory M; Alazez OA; Alhady MA; Nour M; Mokhtar WA
    BMC Pediatr; 2017 Mar; 17(1):69. PubMed ID: 28279156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune Status 'in Children with Beta Thalassemia' in Correlation 'with Iron Overload': Single Center Egyptian Study.
    Hagag AA; Elgamsy MA; El-Asy HM; Gamal RM; Elshahaby WN; Abd Elbar ES
    Endocr Metab Immune Disord Drug Targets; 2016; 16(3):181-188. PubMed ID: 27829333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal glucose tolerance in Egyptian beta-thalassemic patients: possible association with genotyping.
    Khalifa AS; Salem M; Mounir E; El-Tawil MM; El-Sawy M; Abd Al-Aziz MM
    Pediatr Diabetes; 2004 Sep; 5(3):126-32. PubMed ID: 15450007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unbalanced bone turnover in children with beta-thalassemia.
    Salama OS; Al-Tonbary YA; Shahin RA; Eldeen OA
    Hematology; 2006 Jun; 11(3):197-202. PubMed ID: 17325962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher Serum Ferritin Levels Correlate with an Increased Risk of Cutaneous Morbidity in Adult Patients with β-Thalassemia: A Single-Center Retrospective Study.
    Skandalis K; Vlachos C; Pliakou X; Gaitanis G; Kapsali E; Bassukas ID
    Acta Haematol; 2016; 135(2):124-30. PubMed ID: 26509267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deferoxamine-induced dysplasia-like skeletal abnormalities at radiography and MRI.
    Seif El Dien HM; Esmail RI; Magdy RE; Lotfy HM
    Pediatr Radiol; 2013 Sep; 43(9):1159-65. PubMed ID: 23563594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of Serum Immunoglobulin Levels and T lymphocyte Subsets in Children with Beta Thalassemia with Iron Overload in Egypt.
    Hagag AA; Elgamasy MA; Abd Elbar ES
    Egypt J Immunol; 2016 Jan; 23(1):97-105. PubMed ID: 28502157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrinopathies in Turkish children with Beta thalassemia major: results from a single center study.
    Isik P; Yarali N; Tavil B; Demirel F; Karacam GB; Sac RU; Fettah A; Ozkasap S; Kara A; Tunc B
    Pediatr Hematol Oncol; 2014 Oct; 31(7):607-15. PubMed ID: 24854890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to hydroxycarbamide in pediatric β-thalassemia intermedia: 8 years' follow-up in Egypt.
    El-Beshlawy A; El-Ghamrawy M; EL-Ela MA; Said F; Adolf S; Abdel-Razek AR; Magdy RI; Abdel-Salam A
    Ann Hematol; 2014 Dec; 93(12):2045-50. PubMed ID: 25062719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological and radiological study of Egyptian β-thalassemia intermedia and β-thalassemia major patients: relation to complications and response to therapy.
    Mokhtar GM; Tantawy AA; Adly AA; Ismail EA
    Hemoglobin; 2011; 35(4):382-405. PubMed ID: 21797705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular abnormalities in multi-transfused beta-thalassemia patients.
    Jafari R; Heydarian S; Karami H; Shektaei MM; Dailami KN; Amiri AA; Rezaee MR; Far AA
    Indian J Ophthalmol; 2015 Sep; 63(9):710-5. PubMed ID: 26632126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutathione S-transferase gene polymorphism: Relation to cardiac iron overload in Egyptian patients with Beta Thalassemia Major.
    Mokhtar GM; Sherif EM; Habeeb NM; Abdelmaksoud AA; El-Ghoroury EA; Ibrahim AS; Hamed EM
    Hematology; 2016 Jan; 21(1):46-53. PubMed ID: 26288192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Hepcidin as a Diagnostic Marker of Severe Iron Overload in Beta-thalassemia Major.
    Kaddah AM; Abdel-Salam A; Farhan MS; Ragab R
    Indian J Pediatr; 2017 Oct; 84(10):745-750. PubMed ID: 28600663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Beta-thalassemia in Germany. Results of cooperative beta-thalassemia study].
    Cario H; Stahnke K; Kohne E
    Klin Padiatr; 1999; 211(6):431-7. PubMed ID: 10592921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy - deferasirox and deferoxamine - in thalassemia major patients in emerging countries with limited resources.
    Arandi N; Haghpanah S; Safaei S; Zahedi Z; Ashrafi A; Eatemadfar P; Zarei T; Radwan AH; Taher AT; Karimi M
    Transfus Med; 2015 Feb; 25(1):8-12. PubMed ID: 25801075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous disorders in uremic patients on hemodialysis: an Egyptian case-controlled study.
    Attia EA; Hassan SI; Youssef NM
    Int J Dermatol; 2010 Sep; 49(9):1024-30. PubMed ID: 20931673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.